46 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
10498212	3	Preparation and receptor binding affinities of cyclic C-terminal neurotensin (8-13) and (9-13) analogues.	Medical University of South Carolina
27876250	60	Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH	Jagiellonian University Medical College
27842797	42	NTS2-selective neurotensin mimetics with tetrahydrofuran amino acids.	University of Regensburg
26824643	69	Mimicking of Arginine by Functionalized N(¿)-Carbamoylated Arginine As a New Broadly Applicable Approach to Labeled Bioactive Peptides: High Affinity Angiotensin, Neuropeptide Y, Neuropeptide FF, and Neurotensin Receptor Ligands As Examples.	University of Regensburg
26988801	55	Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.	Jagiellonian University Medical College
26348111	32	Synthesis and Characterization in Vitro and in Vivo of (l)-(Trimethylsilyl)alanine Containing Neurotensin Analogues.	University of Montpellier
24997685	39	The discovery of indole full agonists of the neurotensin receptor 1 (NTSR1).	The Scripps Research Institute
25313322	62	Discovery of 2-Pyridylpyrimidines as the First Orally Bioavailable GPR39 Agonists.	Novartis Institutes For Biomedical Research
24332089	35	Imidazole-derived agonists for the neurotensin 1 receptor.	Sanford-Burnham Medical Research Institute
24160350	4	Synthesis and evaluation of a (18)F-labeled diarylpyrazole glycoconjugate for the imaging of NTS1-positive tumors.	Friedrich-Alexander University
24611085	101	Discovery of ML314, a Brain Penetrant Non-Peptidic?-Arrestin Biased Agonist of the Neurotensin NTR1 Receptor.	Sanford-Burnham Medical Research Institute
23582449	20	Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor.	Institute of Organic Synthesis
23466604	36	Synthesis and structure-activity relationship studies in serotonin 5-HT(1A) receptor agonists based on fused pyrrolidone scaffolds.	Universit£
20684563	176	Discovery of N-{1-[3-(3-oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.	H. Lundbeck
18809332	8	Novel insights into GPCR-peptide interactions: mutations in extracellular loop 1, ligand backbone methylations and molecular modeling of neurotensin receptor 1.	Friedrich-Alexander University
16854083	11	Toward stable N4-modified neurotensins for NTS1-receptor-targeted tumor imaging with 99mTc.	National Center For Scientific Research Demokritos
15481995	6	Evaluation of lactam-bridged neurotensin analogues adjusting psi(Pro10) close to the experimentally derived bioactive conformation of NT(8-13).	Friedrich-Alexander University
12954066	63	In vitro analysis of stable, receptor-selective neurotensin[8-13] analogues.	Medical University of South Carolina
12852770	28	Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors.	Washington University
21446649	78	Discovery of highly potent and neurotensin receptor 2 selective neurotensin mimetics.	Friedrich-Alexander University
20813948	63	Spiroindolones, a potent compound class for the treatment of malaria.	Swiss Tropical and Public Health Institute
20591666	66	A new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolase.	Università
20481538	4	Identification and functional characterization of a stable, centrally active derivative of the neurotensin (8-13) fragment as a potential first-in-class analgesic.	Medical University of South Carolina Campus
20452768	3	Synthesis of neurotensin(8-13)-phosphopeptide heterodimers via click chemistry.	Institute of Radiopharmacy
18849166	7	The identification of neurotensin NTS1 receptor partial agonists through a ligand-based virtual screening approach.	Wyeth Research
	3	UK-73,093: A non-peptide neurotensin receptor antagonist	TBA
19290594	64	Comparison of N-terminal modifications on neurotensin(8-13) analogues correlates peptide stability but not binding affinity with in vivo efficacy.	Medical University of South Carolina
19236044	4	Synthesis and applications of polyamine amino acid residues: improving the bioactivity of an analgesic neuropeptide, neurotensin.	University of Utah
19195889	8	The identification of nonpeptide neurotensin receptor partial agonists from the potent antagonist SR48692 using a calcium mobilization assay.	Research Triangle Institute
10743946	7	Synthesis of neurotensin(9-13) analogues exhibiting enhanced human neurotensin receptor binding affinities.	Medical University of South Carolina
31390201	47	Discovery of ?-Arrestin Biased, Orally Bioavailable, and CNS Penetrant Neurotensin Receptor 1 (NTR1) Allosteric Modulators.	Sanford Burnham Prebys Medical Discovery Institute
31158752	6	Enhanced tumor retention of NTSR1-targeted agents by employing a hydrophilic cysteine cathepsin inhibitor.	University of Nebraska Medical Center
32184966	13	An Alkyne-functionalized Arginine for Solid-Phase Synthesis Enabling "Bioorthogonal" Peptide Conjugation.	University of Regensburg
31938457	40	Fluorescence Labeling of Neurotensin(8-13) via Arginine Residues Gives Molecular Tools with High Receptor Affinity.	University of Regensburg
31223455	12	Modifications at Arg and Ile Give Neurotensin(8-13) Derivatives with High Stability and Retained NTS	University of Regensburg
29541365	15	In Search of the Optimal Macrocyclization Site for Neurotensin.	Universit£
30035538	69	Structural Optimization and Characterization of Potent Analgesic Macrocyclic Analogues of Neurotensin (8-13).	Universit£
29631962	252	Identification and biological evaluation of thiazole-based inverse agonists of ROR?t.	Phenex Pharmaceuticals
28368584	16	Use of Molecular Modeling to Design Selective NTS2 Neurotensin Analogues.	University of Montpellier
17005826	27	Structure-activity relationships of Bacillus cereus and Bacillus anthracis dihydrofolate reductase: toward the identification of new potent drug leads.	University of Connecticut At Storrs